Physician profile
Frederick Stephen Moore
NPI 1104876440
$568.89
in general payments reported to CMS, 2019-2025
9 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $88.96 · 2021: $97.52 · 2023: $42.41 · 2024: $52.95 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $143.30 | 2019-2023 | |
| Boston Scientific Corporation | $114.27 | 2025 | X-Tack Endoscopic Helix Tacking System |
| Ambu INC. | $97.52 | 2021 | |
| Novo Nordisk INC | $88.96 | 2020 | |
| Madrigal Pharmaceuticals | $38.74 | 2025 | Rezdiffra |
| Pfizer INC. | $28.70 | 2024-2025 | |
| Genzyme Corporation | $23.82 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.73 | 2025 | Entyvio |
| Phathom Pharmaceuticals, INC. | $15.85 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.